Investor profile
Lauxera Capital Partners has backed 5 European tech companies across 5 funding rounds between 2021 and 2026, joining rounds totalling €293M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Caresyntax | Germany | 1 | €164M |
| Natural Cycles | Sweden | 1 | €51M |
| Lifen | France | 1 | €50M |
| Organox | UK | 1 | €29M |
| GenePlanet | Slovenia |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Caresyntax | Series C | €164M | 2024-08 |
| Natural Cycles | Series C | €51M | 2024-05 |
| Lifen | Series C | €50M | 2021-11 |
| Organox |
| 1 |
| €0 |
| €29M |
| 2023-07 |
